RE:GlobeNewswireGreat news! This seems to align well with the progression towards PHI for PMN310 and the intended use of biomarkers. In the past, PMN had talked about this as a great tool. Now it appears they are talking about it as a new product that leverages PMN's proprietary technology.
Have a good day everyone.